Trial Profile
Efficacy and tolerability of sorafenib in patients with differentiated thyroid cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Sep 2015 New trial record